Fenglei Yu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
Papers in
-
- Lung Cancer Diagnosis and Treatment 16
- Lung Cancer Treatments and Mutations 16
- Ferroptosis and cancer prognosis 7
-
- RNA modifications and cancer 15
- Epigenetics and DNA Methylation 7
- Cancer-related gene regulation 7
- Co-authors
- Xiang Wang (25 shared papers)Muyun Peng (30 shared papers)Chen Chen (25 shared papers)Yongguang Tao (10 shared papers)Ya Cao (6 shared papers)Wenliang Liu (35 shared papers)Chao Mao (5 shared papers)Desheng Xiao (5 shared papers)
- Journals
- Frontiers in Oncology (6 papers)Journal of Clinical Oncology (5 papers)Cancer Investigation (4 papers)The Annals of Thoracic Surgery (4 papers)Scientific Reports (4 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Fenglei Yu
107 papers receiving 2.6k citations
Fenglei Yu's Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 895
- Pulmonary and Respiratory Medicine 855
- Oncology 494
- Molecular Biology 1.1k
- Immunology 234
Countries citing papers authored by Fenglei Yu
This map shows the geographic impact of Fenglei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglei Yu more than expected).
Fields of papers citing papers by Fenglei Yu
This network shows the impact of papers produced by Fenglei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglei Yu. The network helps show where Fenglei Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fenglei Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA Hit paper breakdown → | 2019 | 433 |
| 2 | 2017 | 243 | |
| 3 | 2017 | 182 | |
| 4 | 2017 | 110 | |
| 5 | 2017 | 91 | |
| 6 | 2018 | 76 | |
| 7 | 2020 | 74 | |
| 8 | 2019 | 59 | |
| 9 | 2015 | 55 | |
| 10 | 2012 | 55 | |
| 11 | 2021 | 54 | |
| 12 | 2013 | 51 | |
| 13 | 2019 | 51 | |
| 14 | 2020 | 48 | |
| 15 | 2020 | 47 | |
| 16 | 2014 | 46 | |
| 17 | 2013 | 45 | |
| 18 | 2007 | 45 | |
| 19 | 2011 | 45 | |
| 20 | 2019 | 43 |
About Fenglei Yu
Fenglei Yu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Surgery, having authored 120 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (16 papers), RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (10 papers), Cancer Genomics and Diagnostics (9 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (7 papers) and Ferroptosis and cancer prognosis (7 papers). The work is most often cited by research in Cancer Research (895 citations), Pulmonary and Respiratory Medicine (855 citations), Oncology (494 citations), Molecular Biology (1.1k citations) and Immunology (234 citations). Fenglei Yu has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Xiang Wang, Muyun Peng, Chen Chen, Yongguang Tao, Ya Cao, Wenliang Liu, Chao Mao, Desheng Xiao, Qin Yan and Weiwei Lai. Their work appears in journals such as Frontiers in Oncology, Journal of Clinical Oncology, Cancer Investigation, The Annals of Thoracic Surgery and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.